Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases

BACKGROUND: The incidence of gastric cancer with liver metastases (GCLM) is 9.9–18.7%, with a median survival time of 11 months and a 5-year survival rate <20%. Multidisciplinary treatment (MDT) is gradually gaining recognition as the most important method. However, specific treatment plans remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kecheng, Chen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036491/
https://www.ncbi.nlm.nih.gov/pubmed/32127925
http://dx.doi.org/10.1177/1758835920904803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036491/
https://www.ncbi.nlm.nih.gov/pubmed/32127925
http://dx.doi.org/10.1177/1758835920904803

Ejemplares similares